Medicare Advantage (Part C) & Part D Plans: Medicare has historically been very restrictive about covering drugs for weight loss
Last reviewed: July 10, 2026 Last updated: July 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Latest Clinical Progress (as of early 2026) Phase 1 Clinical Data: Preliminary results presented at the 2025 American Heart Association (AHA) Annual Meeting showed that after a single dose, patients experienced a maximum reduction in serum AGT levels of over 95%
Enhanced dosing flexibility and cost-effectiveness
Workflow Changes: Previously, some PAs were done by phone (pharmacists calling physicians)
Quick answer: 2.5 mg of tirzepatide equals 25 units on a standard U-100 insulin syringe when your vial concentration is 10 mg/mL the most common compounded strength